%0 Journal Article
%A Wang, Yanling
%A Yang, Xiaoxuan
%A Ma, Jia
%A Chen, Shenglan
%A Gong, Ping
%A Dai, Ping
%T Thyroid dysfunction (TD) induced by PD-1/PD-L1 inhibitors in advanced lung cancer.
%J Heliyon
%V 10
%N 5
%@ 2405-8440
%C London [u.a.]
%I Elsevier
%M DKFZ-2024-00491
%P e27077
%D 2024
%Z #LA:E055#
%X Thyroid Dysfunction (TD) is a common immune-related adverse events (irAEs) in the treatment of advanced lung cancer with programmed cell death protein 1 (PD-1) and programmed death 1 ligand (PD-L1) inhibitors, with incidence accounting for 6-8
%K Advanced lung cancer (Other)
%K Efficacy (Other)
%K Immune checkpoint inhibitors (Other)
%K PD-1/PD-L1 inhibitors (Other)
%K Thyroid dysfunction (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:38449616
%2 pmc:PMC10915392
%R 10.1016/j.heliyon.2024.e27077
%U https://inrepo02.dkfz.de/record/288826